A Study to Evaluate the Safety, Tolerability & Efficacy of MSDC-0602K in Patients With NASH
Public ClinicalTrials.gov record NCT02784444. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, 12-Month, Multiple-Dose Study to Evaluate the Safety, Tolerability and Efficacy of Three Dose Levels of MSDC-0602K in Patients With NASH (EMMINENCE™)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a randomized, double-blinded study of three doses of MSDC-0602K or placebo given orally once daily to subjects with biopsy proven NASH with fibrosis and no cirrhosis.
Study identification
- NCT ID
- NCT02784444
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 392 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 14, 2016 (Actual)
- Primary completion
- Jun 2019 (Actual)
- Completion
- Jun 2019 (Actual)
- Last update posted
- Sep 16, 2020
2016 – 2019
United States locations
- U.S. sites
- 43
- U.S. states
- 14
- U.S. cities
- 40
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Chandler | Arizona | 85224 | — |
| Not listed | Tucson | Arizona | 85712 | — |
| Not listed | Chula Vista | California | 91910 | — |
| Not listed | Fresno | California | 93701 | — |
| Not listed | Garden Grove | California | 92844 | — |
| Not listed | Huntington Park | California | 90255 | — |
| Not listed | La Mesa | California | 91942 | — |
| Not listed | Los Angeles | California | 90036 | — |
| Not listed | Los Angeles | California | 90057 | — |
| Not listed | Poway | California | 92064 | — |
| Not listed | Rialto | California | 92377 | — |
| Not listed | San Diego | California | 92103 | — |
| Not listed | Englewood | Colorado | 80113 | — |
| Not listed | Gainesville | Florida | 32610 | — |
| Not listed | Hialeah | Florida | 33016 | — |
| Not listed | Inverness | Florida | 34452 | — |
| Not listed | Lakewood Rch | Florida | 34211 | — |
| Not listed | Miami Lakes | Florida | 33016 | — |
| Not listed | Wellington | Florida | 33414 | — |
| Not listed | Marietta | Georgia | 30060 | — |
| Not listed | Indianapolis | Indiana | 46202 | — |
| Not listed | Bastrop | Louisiana | 71220 | — |
| Not listed | New Orleans | Louisiana | 70112 | — |
| Not listed | New Orleans | Louisiana | 70115 | — |
| Not listed | West Monroe | Louisiana | 71291 | — |
| Not listed | Flowood | Mississippi | 39232 | — |
| Not listed | Brooklyn | New York | 112301 | — |
| Not listed | New York | New York | 10018 | — |
| Not listed | Fayetteville | North Carolina | 28304 | — |
| Not listed | Greenville | North Carolina | 27834 | — |
| Not listed | Statesville | North Carolina | 28677 | — |
| Not listed | Providence | Rhode Island | 02905 | — |
| Not listed | Germantown | Tennessee | 38138 | — |
| Not listed | Hermitage | Tennessee | 37076 | — |
| Not listed | Arlington | Texas | 76012 | — |
| Not listed | Dallas | Texas | 75203 | — |
| Not listed | Fort Sam Houston | Texas | 78234 | — |
| Not listed | Houston | Texas | 77030 | — |
| Not listed | Live Oak | Texas | 78233 | — |
| Not listed | Rollingwood | Texas | 78746 | — |
| Not listed | San Antonio | Texas | 78215 | — |
| Not listed | San Antonio | Texas | 78265 | — |
| Not listed | Richmond | Virginia | 23249 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02784444, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 16, 2020 · Synced Oct 8, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02784444 live on ClinicalTrials.gov.